Zhejiang Taimei Medical Technology Co., Ltd. (Ticker: 2576.HK) is a medical and aesthetic services company providing digital solutions for pharmaceutical and medical device research, development, and commercialization in China and certain overseas markets. Zhejiang Taimei Medical Technology will list H Shares on the Hong Kong Stock Exchange (HKEX) on October 8, 2024.

The company is offering shares at a price range of HKD 10.00 to HKD 13.00. The expected market capitalization at the offer is HKD 5.60 billion to HKD 7.29 billion (USD 828.75 million). The total offer size is USD 33.15 million. The offering is managed by Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities Limited, along with other underwriters.